U.S. Health Care REITs Stock News

NYSE:ROL
NYSE:ROLCommercial Services

Rollins Weighs Growth Options As Orkin Mosquito Data Highlights Urban Demand

Orkin, a Rollins (NYSE:ROL) brand, released its 2026 Mosquito Cities List, ranking U.S. metro areas based on mosquito activity. Large cities such as Los Angeles, Chicago, and New York feature prominently on the list, pointing to wider geographic mosquito pressure. Orkin is working with the American Red Cross on a national campaign during peak mosquito season focused on awareness and community support. For Rollins, a company focused on residential and commercial pest control services, the...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

MarketAxess Partnership With Moment Tests New Growth In Advisor Channels

MarketAxess Holdings (NasdaqGS:MKTX) announced a new partnership with Moment. The collaboration connects MarketAxess’s institutional fixed income liquidity and pricing to wealth managers and retail advisors via the Moment platform. The deal extends MarketAxess’s reach beyond traditional institutional clients into larger wealth management and registered investment advisor channels. MarketAxess runs an electronic trading platform focused on corporate and other fixed income securities,...
NYSE:CVSA
NYSE:CVSAConsumer Services

Is Covista (CVSA) Offering Value After Recent Share Price Gains?

This article walks through key numbers to help you judge whether Covista is priced attractively or already fully valued, so you can compare the stock against your own expectations. Covista recently closed at US$118.07, with returns of 4.3% over the last week, 0.1% over the past month, 13.0% year to date and 4.7% over the last year. Recent coverage around Covista has focused on its share price performance and how investors are reassessing the stock in light of broader sector moves. This...
NYSE:RCUS
NYSE:RCUSBiotechs

Is It Too Late To Consider Arcus Biosciences (RCUS) After Its 221% One Year Surge?

If you are wondering whether Arcus Biosciences is reasonably priced or getting ahead of itself, the current share price invites a closer look at what investors may actually be paying for. The stock last closed at US$26.06, with returns of 5.1% over the past 7 days, 13.5% over 30 days, 11.9% year to date, and 220.9% over the last year, which points to a stock that has already seen significant movement. Recent coverage around Arcus Biosciences has focused on its position in the biotech space...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Is It Time To Reconsider Upstart Holdings (UPST) After Recent Share Price Swings?

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

ARK Invest’s NTLA Buy Puts Dilution And CRISPR Progress In Focus

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look At Soleno Therapeutics (SLNO) Valuation After Recent Share Momentum And VYKAT XR Launch Progress

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...
NYSE:ITGR
NYSE:ITGRMedical Equipment

Integer Holdings Review Tests Shareholder Value As Profitability Improves

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...
NasdaqGS:WABC
NasdaqGS:WABCBanks

A Look At Westamerica Bancorporation (WABC) Valuation After Expanded Buyback And Dividend Increase

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...
NasdaqGM:RMIX
NasdaqGM:RMIXBasic Materials

Suncrete Adds Industry Veterans To Board As Investors Weigh Share Pullback

Suncrete (NasdaqGM:RMIX) has appointed Charles Owens and Noreen Skelly as independent directors to its Board. Both Owens and Skelly have also joined the Audit Committee, with Skelly serving as Chair. The appointments expand the Board and Audit Committee with additional construction and banking sector expertise. Suncrete, trading at around $15.4, has seen its share price move 38.9% over the past 30 days and 35.1% year to date, with a 39.1% return over the past year and a 2.7% decline over...
NYSE:ONON
NYSE:ONONLuxury

On Holding Discounting Puts Premium Pricing And Growth Story Under Review

Emerging discounting on core On Holding products at key retailers and outlets has raised fresh questions about the strength of the NYSE:ONON premium brand. Channel checks highlight margin pressure in the wholesale channel, challenging recent messaging around full price discipline and margin expansion. The news follows the return of the co founders as co CEOs and arrives as investors reassess growth and profitability expectations. On Holding, trading at $34.59 under ticker NYSE:ONON, is...
NYSE:FAF
NYSE:FAFInsurance

Is It Too Late To Consider First American Financial (FAF) After Its 17% Monthly Surge?

Investors may be wondering if First American Financial at around US$68 per share still offers value, or if most of the easy gains are already on the table. The stock is up 17.4% over the last 30 days and 12.0% year to date, with a 15.6% return over the past year and a 31.1% return over three years. These changes can influence how the market is pricing its risks and opportunities. These moves are playing out against a backdrop of ongoing interest in US insurance stocks and property related...